Figure 4

Prognostic evaluation of DNAM-1 in AML. (A) Overall survival of patients divided into quartiles according to DNAM-1 expression is depicted. (B) Separation of the cohort into DNAM-1^high and DNAM-1^low groups using cut-off value of 31.5% positive cells is illustrated. (C,D) Overall and progression-free (E,F) survival of patients assigned to the DNAM^high and DNAM^low groups based on the cut-off value 31.3%; (C,D)—all patients, (E,F)—patients subjected to allogeneic stem cell transplantation (HSCT) is shown; statistical significance was assessed using log-rank test.